Business Wire

IQM

Share
IQM: Unimon - A New Qubit to Boost Quantum Computers for Useful Applications

A group of scientists from IQM Quantum Computers, Aalto University, and VTT Technical Research Centre of Finland have discovered a new superconducting qubit, the unimon, to increase the accuracy of quantum computations. The team has achieved the first quantum logic gates with unimons at 99.9% fidelity — a major milestone on the quest to build commercially useful quantum computers. This pivotal piece of research was just published in the journal Nature Communications.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115005803/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Figure. Artistic impression of a unimon qubit in a quantum processor. Credits: Aleksandr Kakinen. (Graphic: Business Wire)

Of all the different approaches to build useful quantum computers, superconducting qubits are on the lead. However, the qubit designs and techniques currently used do not yet provide high enough performance for practical applications. In this noisy intermediate-scale quantum (NISQ) era, the complexity of the implementable quantum computations is mostly limited by errors in single- and two-qubit quantum gates. The quantum computations need to become more accurate to be useful.

“Our aim is to build quantum computers which deliver an advantage in solving real-world problems. Our announcement today is an important milestone for IQM and a significant achievement to build better superconducting quantum computers,” said Mikko Möttönen, Joint Professor of Quantum Technology at Aalto University and VTT, and also a Co-Founder and Chief Scientist at IQM Quantum Computers, who was leading the research.

Today, IQM has introduced a new superconducting-qubit type, the unimon, which unites in a single circuit the desired properties of increased anharmonicity, full insensitivity to dc charge noise, reduced sensitivity to magnetic noise, and a simple structure consisting only of a single Josephson junction in a resonator. The team achieved fidelities from 99.8% to 99.9% for 13-nanoseconds-long single-qubit gates on three different unimon qubits.

“Because of the higher anharmonicity, or non-linearity, than in transmons, we can operate the unimons faster, leading to fewer errors per operation,” said Eric Hyyppä who is working on his PhD at IQM.

To experimentally demonstrate the unimon, the scientists designed and fabricated chips, each of which consisted of three unimon qubits. They used niobium as the superconducting material apart from the Josephson junctions, in which the superconducting leads were fabricated using aluminum.

“I would like to thank and congratulate Eric and the other team members who worked tirelessly for this major achievement,” said Prof. Möttönen.

The team measured the unimon qubit to have a relatively high anharmonicity while requiring only a single Josephson junction without any superinductors, and bearing protection against noise. The geometric inductance of the unimon has the potential for higher predictability and yield than the junction-array-based superinductors in conventional fluxonium or quarton qubits.

“Unimons are so simple and yet have many advantages over transmons. The fact that the very first unimon ever made worked this well gives plenty of room for optimization and major breakthroughs. As next steps, we should optimize the design for even higher noise protection and demonstrate two-qubit gates,” added Prof. Möttönen.

IQM’s commercial quantum computers still use transmon qubits. With transmons, IQM already delivers on-premises quantum computers, for example IQM is building Finland’s first 54-qubit quantum computer as part of a co-innovation project with VTT Technical Research Center of Finland, and an IQM-led consortium Q-Exa is also building a 20-qubit quantum computer in Germany, to be integrated to a supercomputer. The unimon invented now is an alternative qubit that may lead to higher accuracy in quantum computations in the future.

“We aim for further improvements in the design, materials, and gate time of the unimon to break the 99.99% fidelity target for useful quantum advantage with noisy systems and efficient quantum error correction. This is a very exciting day for quantum computing!” concluded Prof. Möttönen.

About IQM Quantum Computers:

IQM is the pan-European leader in building quantum computers. IQM provides on-premises quantum computers for supercomputing data centers and research labs and offers full access to its hardware. For industrial customers, IQM strives for quantum advantage through a unique application-specific, co-design approach. IQM is building Finland’s first 54-qubit quantum computer with VTT, and an IQM-led consortium (Q-Exa) is also building a quantum computer in Germany. This computer will be integrated into an HPC supercomputer to create a quantum accelerator for future scientific research. IQM has over 200 employees with offices in Paris, Madrid, Munich, and Espoo.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221115005803/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release

Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management

Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release

Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release

- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc

Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release

IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye